Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.Reviva Pharmaceuticals Holdings, Inc.

Reviva Pharmaceuticals Holdings, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪36.97 M‬USD
−1.59USD
‪−39.26 M‬USD
‪24.87 M‬
Beta (1Y)
1.00

About Reviva Pharmaceuticals Holdings, Inc.

CEO
Laxminarayan Bhat
Headquarters
Cupertino
Employees (FY)
15
Founded
2020
FIGI
BBG00LJZ8FW8
Reviva Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the central nervous system, respiratory, and metabolic diseases. It uses chemical genomics driven technology platform and proprietary chemistry to develop new medicines. It focuses on the RP5063 (Brilaroxazine) and RP1208 pipelines. The company was founded by Laxminarayan Bhat on December 11, 2020 and is headquartered in Cupertino, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RVPH is 1.24 USD — it has decreased by 2.36% in the past 24 hours. Watch Reviva Pharmaceuticals Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Reviva Pharmaceuticals Holdings, Inc. stocks are traded under the ticker RVPH.
RVPH stock has risen by 16.98% compared to the previous week, the month change is a 16.78% fall, over the last year Reviva Pharmaceuticals Holdings, Inc. has showed a 74.59% decrease.
We've gathered analysts' opinions on Reviva Pharmaceuticals Holdings, Inc. future price: according to them, RVPH price has a max estimate of 17.00 USD and a min estimate of 6.00 USD. Watch RVPH chart and read a more detailed Reviva Pharmaceuticals Holdings, Inc. stock forecast: see what analysts think of Reviva Pharmaceuticals Holdings, Inc. and suggest that you do with its stocks.
RVPH reached its all-time high on Dec 7, 2020 with the price of 15.10 USD, and its all-time low was 0.53 USD and was reached on Aug 1, 2022. View more price dynamics on RVPH chart.
See other stocks reaching their highest and lowest prices.
RVPH stock is 9.32% volatile and has beta coefficient of 1.00. Track Reviva Pharmaceuticals Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Reviva Pharmaceuticals Holdings, Inc. there?
Yes, you can track Reviva Pharmaceuticals Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Reviva Pharmaceuticals Holdings, Inc. is going to release the next earnings report on Aug 12, 2024. Keep track of upcoming events with our Earnings Calendar.
RVPH earnings for the last quarter are −0.25 USD per share, whereas the estimation was −0.38 USD resulting in a 33.63% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Reviva Pharmaceuticals Holdings, Inc. earnings.
Reviva Pharmaceuticals Holdings, Inc. revenue for the last quarter amounts to 0 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RVPH net income for the last quarter is ‪−7.43 M‬ USD, while the quarter before that showed ‪−9.72 M‬ USD of net income which accounts for 23.56% change. Track more Reviva Pharmaceuticals Holdings, Inc. financial stats to get the full picture.
No, RVPH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 15, 2024, the company has 15.00 employees. See our rating of the largest employees — is Reviva Pharmaceuticals Holdings, Inc. on this list?
Like other stocks, RVPH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Reviva Pharmaceuticals Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Reviva Pharmaceuticals Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Reviva Pharmaceuticals Holdings, Inc. stock shows the sell signal. See more of Reviva Pharmaceuticals Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.